INTRODUCTION
In the United States, men who have sex with men (MSM) continue to be disproportionately affected by HIV. Although MSM represent only 3%-10% of the US. population, 1 they account for nearly 60% of new HIV infections. 2 Nationally, young, black, and Hispanic MSM represent a majority of new infections, 3, 4 and these trends persist at the local level in Washington, DC and Miami-Dade County, Florida, 2 racially and ethnically diverse HIV epicenters. 5, 6 In 2010, data from one of the first studies on the efficacy of HIV-antiretroviral medication (ARV) as HIV prevention provided evidence for the use of pre-exposure prophylaxis (PrEP) for HIV prevention among MSM. 7 Based on additional evidence from subsequent trials, [8] [9] [10] the US. Food and Drug Administration (FDA) approved Truvada (Tenofovir disoproxil/emtricitabine) for use as once-daily oral PrEP in 2012, 11 and the Centers for Disease Control and Prevention (CDC) released clinical recommendations for the use of PrEP in 2014. 12 Although there were initial concerns that PrEP would be ineffective in realworld use because of issues with adherence and risk compensation, PrEP studies outside of clinical trial populations have shown promising results among those with higher levels of adherence and those who remained on the intervention, compared with those who discontinued taking PrEP. 13 Open-label demonstration studies in the US. and England have shown high levels of protection against HIV. 14, 15 Volk et al 16 found no new HIV infections among PrEP users attending a clinic in San Francisco, CA, over 388 person-years of follow-up, despite high rates of sexually transmitted infections and a reported decrease in condom use among a subset of participants.
Despite these promising findings, initial uptake of PrEP outside of research and demonstration projects has been slow. An analysis of US. pharmacy data from 2012 to 2014, found 3253 unique individuals, 68% of whom were men, had used PrEP. 17 More recent studies, however, have found significant increases in PrEP use, as reported by urban and internet-based samples of MSM. Between 2013 and 2015, PrEP use among MSM in New York City increased from 2.1% to 14.8%. 18 A national internet sample of MSM found significant increases in selfreported PrEP use in MSM in several US cities from 2012 to 2015. 19 A study of high-risk MSM in Seattle, WA, found the largest reported increase in PrEP use from 5% to 31% between 2012 and 2015, with 23% currently taking PrEP. 20 Although these studies reveal increases in PrEP use, there is still much work to be done in light of the estimated 492,000 MSM eligible for PrEP in the US. 21 Understanding knowledge of and willingness to use PrEP among MSM at high-risk for HIV is an important step to increasing PrEP utilization. To date, few studies have examined willingness to use PrEP among MSM. Before FDA approval in 2012, Mimiaga et al 22 found that while knowledge of PrEP was low among MSM in Boston, there was a high level of interest in using PrEP. Among MSM in Denver, between 2008 and 2014 awareness significantly increased over time, but less than 50% had ever heard of PrEP in 2014, and willingness to use PrEP did not significantly change over time. 23 A recent study of 206 highly sexually active MSM in New York City, between 2011 and 2013, also found no significant change in willingness, despite a significant increase in awareness of PrEP, from 53% to 72%. 24 In a national study among internet-recruited MSM, a slight increase in self-reported willingness to use PrEP was found between 2012 and 2015, 19 increasing from 39.3% to 49.6%.
Given the increasing rates of HIV among MSM and the need for increased prevention efforts, it is imperative that we better understand the awareness and uptake of PrEP in communities that have been highly impacted by HIV to target PrEP-related prevention programming. This study examines changes in awareness of PrEP, self-reported use, and degree of willingness to use PrEP among a communityrecruited sample of sexually active MSM from 2011 to 2014 in 2 urban areas highly impacted by HIV-Washington, DC and Miami-Dade County, FL. Demographic characteristics, and sexual and substance use behaviors were assessed as correlates of self-reported willingness to use PrEP in both 2011 and 2014.
METHODS
Washington, DC and Miami-Dade County, FL, 2 urban centers with high HIV prevalence, were funded by the CDC through the Enhanced Comprehensive HIV Prevention Planning Initiative (ECHPP) to maximize uptake of high-impact HIV prevention interventions. 25 As a part of this initiative, the Centers for AIDS Research in Washington, DC and MiamiDade County, FL proposed a collaboration to examine PrEP uptake through the role of both the provider and potential consumers. 26, 27 To address the latter aim, 2 measures were added to the supplemental local NHBS questions in both cities to assess willingness to use PrEP and perceptions of condom use behavior if using PrEP.
Data from the CDC National HIV Behavioral Surveillance (NHBS) system conducted in Washington, DC and Miami-Dade County, FL during the 2011 (MSM-3) and 2014 (MSM-4) data collection cycles focusing on MSM were analyzed. The NHBS system began in 2003 and during 2011 and 2014, the years of data collection used in this analysis, NHBS was conducted in 20 cities. NHBS is a serial, cross-sectional behavioral surveillance community survey that is conducted among 3 populations at highest risk for HIV: MSM, persons who use injection drugs, and heterosexuals at elevated risk for HIV. Recruitment for the MSM cycles in this analysis were completed in 2011 and 2014, and interviews were conducted among men recruited using venue-based time-space sampling (VBS). 28 Briefly, in each city, a sampling frame of all eligible venues was generated using formative research that included all potential public venues from which MSM could be recruited. Eligible venues were those at which at least 50% of the male attendees were MSM (assessed by formative research, including street intercept interviews). Venues and days and times of the week were randomly selected for communitybased recruitment on a monthly basis.
Study eligibility included being male assigned at birth and currently identifying as male, 18 years of age or older, having had sex with a man in the past year, and living in the metropolitan statistical area in which the study was conducted. Men were approached and screened by study staff to ascertain eligibility to participate in the survey, and eligible individuals were consented and completed a face-to-face interviewer-administered behavioral survey using a handheld or tablet computer. Questions included demographic characteristics, sexual and drug use risk behaviors, HIV-testing behaviors, and utilization of HIV prevention programs. All participants were offered rapid HIV testing; self-reported and preliminary HIV-positive individuals were confirmed using western blot and were immediately referred to care. Individuals received incentives for completing the survey ($25 in Washington, DC and $25 in Miami-Dade County, FL) and for being tested for HIV ($10 in Washington, DC and $25 in Miami-Dade County, FL).
Measures
To assess awareness and use of ARVs as HIV prevention, participants were asked whether they had "ever heard of people who do not have HIV taking anti-HIV medicines, to keep from getting HIV?" and if they had used PrEP in the last 12 months. Participants who reported any PrEP use in the last 12 months were also asked where they received ARVs (doctor or health care provider, sex partner, friend or relative, internet, or some other location).
To assess willingness to use PrEP, participants were presented with a scenario in which daily oral PrEP was available for free or covered by their health insurance and asked how likely they would be to take it with the following response options: "very likely," "somewhat likely," or "not at all likely." For this analysis, participants responding very likely were considered to be willing to use PrEP, whereas those responding as being somewhat or not at all likely to use PrEP were coded as not being willing to use PrEP. An additional follow-up question was asked regarding whether participants strongly agreed, agreed, disagreed, or strongly disagreed with the statement "If I am taking HIV medicines to prevent HIV infection, I will no longer need to use condoms or practice safer sex." For this analysis, responses were dichotomized as "strongly agree/agree" and "strongly disagree/disagree."
Data Analysis
All analyses were stratified by city. Demographic characteristics, sexual risk and drug use behaviors, and HIV-testing behaviors, as well as reported awareness, use, and willingness to use PrEP were examined in both 2011 and 2014. For categorical variables, frequencies were reported by cycle year, and x 2 or Fisher exact tests were used to assess differences in the distribution of variables across cycle years. Logistic regression was used to generate unadjusted and adjusted odds ratios (ORs and aORs, respectively) and 95% confidence intervals (CIs) to assess correlates of being "very likely" vs. "somewhat/not at all likely" to use PrEP. To For this analysis, the sample was limited to participants who responded to locally-developed questions on willingness to use PrEP. Self-reported HIV-positive individuals were also excluded because this analysis focuses on use of and willingness to use PrEP for HIV prevention. Because HIV rapid test results were given after the survey was finished, individuals who were newly identified as preliminary positive were included in this analysis as their responses were captured before disclosure of results. Therefore, in both cities, a total of 602 confirmed HIV negative or newlydiagnosed MSM were included in 2011 (n = 323 in Washington, DC and n = 279 in Miami-Dade County, FL) and 774 were included in 2014 (n = 313 in Washington, DC and n = 431 in Miami-Dade County, FL). All analyses were completed using SAS version 9.3 (Cary, NC). and 2014 (Washington, DC: 4.7% vs. 8.7%, respectively; P = 0.04; Miami-Dade County, Fl: 5.3% vs. 9.8%, respectively; P = 0.04). Univariate and multivariate analyses revealed several differences between 2011 and 2014 in both Washington, DC and Miami-Dade County, FL, and results are presented separately by city (Table 3) .
RESULTS

As seen in
Washington, DC
In 2011, the characteristics positively associated with being very likely to use PrEP included: being younger than 35 years (18-24 years: OR = 3.40; 95% CI: 1.78 to 6.48; 25-34 years: OR = 2.04; 95% CI: 1.22 to 3.39), being Hispanic vs. white (OR = 3.50; 95% CI: 1.52 to 8.05), an annual household income ,$20,000 compared with $40,000 or more (OR = 2.53; 95% CI: 1.22 to 5.21), and infrequent binge drinking (,1/wk) vs. never drinks (OR = 2.57; 95% CI: 1.04 to 6.37). In the multivariate model, younger MSM (18-24 years old) were more than twice as likely (OR = 2.28; 95% CI: 1.08 to 4.84) to report being very likely to use PrEP compared with MSM 35 years or older. Hispanic MSM also had higher odds of being very likely to use PrEP compared with white MSM (OR = 3.85; 95% CI: 1.56 to 9.51). MSM reporting 2-5 male sexual partners in the last 12 months had reduced odds of being very likely to use PrEP compared with those with 6 or more partners (OR = 0.55; 95% CI: 0.31 to 0.95).
In 2014, MSM reporting fewer than 6 male sexual partners (vs. 6+) had decreased odds of being very likely to use PrEP (1 partner: OR = 0.46; 95% CI: 0.23 to 0.94; 2-5 partners: OR = 0.58; 95% CI: 0.36 to 0.93). When compared with white MSM, black MSM had higher odds of being very likely to use PrEP; although this was not statistically significant, this was retained in the overall adjusted model. In 2014, the independent correlates of being very likely to use PrEP included being black (OR = 1.80; 95% CI: 1.04 to 3.13) and having 1 (OR = 0.38; 95% CI: 0.18 to 0.80) or 2-5 (OR = 0.45; 95% CI: 0.27 to 0.75) compared with 6 or more male sexual partners in the last 12 months. [14] [15] [16] This may be of concern, given that behavior changes, such as increased condomless sex, may continue even if a person discontinues PrEP use, thus potentially resulting in heightened HIV risk over time.
Miami-Dade County, FL
Two years after FDA approval and nearly 4 years after release of the iPrEX study results, PrEP use was low in both cities. In 2014, PrEP use among MSM in MiamiDade County, FL was similar to internet-recruited MSM residing in rural areas 19 and in San Francisco before the release of iPrEX data, 29 whereas Washington, DC was comparable with internet-recruited MSM from Los Angeles and Chicago between 2014 and 2015. 19 Although PrEP use in both cities was low compared with some recent findings among samples of high-risk MSM, 20,24 our sample was not limited to MSM exhibiting high-risk behaviors, and thus might be expected to be lower. Slow uptake even with increased awareness in both jurisdictions, may be related to stigma associated with being assumed HIV positive or being labeled "high-risk" as result of using PrEP. 30 The US PrEP Demonstration project found that overall uptake of PrEP was high when offered in STD clinics and a community health center, and that participants from Miami or Washington, DC and those who reported previous knowledge of PrEP were more likely to enroll. 31 These findings indicate the potential for future increases in PrEP use as both cities expand access to and promotion of PrEP.
Although other studies have seen slight increases over time in willingness to use PrEP, 19, 24 our study found substantial changes in being willing to use PrEP in both cities. The direction of this change varied, with a lower proportion of MSM in Washington, DC and a higher proportion of MSM in Miami-Dade County, FL to report being very likely to use PrEP in 2014 vs. 2011. These differences may be related to the level of awareness around PrEP in each city, since less than 50% of MSM in Miami had heard of PrEP in 2014 compared with over 70% in Washington, DC. Between 2011 and 2014, both Miami-Dade County, FL and Washington, DC were sites for the US PrEP Demonstration Project, which similarly found that participants in MiamiDade County, FL reported lower PrEP awareness than those in Washington, DC. 31 In addition, Washington, DC was also a site for HPTN 069 32 and HPTN 073. 33 The presence of more PrEP trials before and during data collection in 2014, may partially explain the higher level of awareness of PrEP in Washington, DC relative to Miami-Dade County, FL.
The results of this study should be considered in the context of its limitations. These samples were recruited using VBS; thus these results may not be generalizable to nonvenue attending MSM. These data were not weighted to account for variation in venue attendance or likelihood of being selected, which may have also result in the decreased ability to generalize behaviors across men who do attend venues. This study is based on self-report data, which may be affected by recall or social desirability bias, but this is appropriate to outcome measures which include perceptions and are otherwise unmeasurable. Although interviewers were highly trained and routine data quality checks were conducted, there was the possibility of recording errors and intrainterviewer/interinterviewer differences in administration. In addition, increases in awareness and uptake in 2014 may be driven by local PrEP demonstration projects that had already been launched in these respective municipalities, and therefore, these data may actually reflect the effects of local public health programming. Last, because of data sharing restrictions, we were unable to conduct between city analyses.
To our knowledge, this is one of the first studies to examine degree of willingness to use PrEP among community-recruited MSM over time, before large-scale public health efforts in each city to increase PrEP uptake. 34, 35 Our findings show that although awareness of PrEP may be increasing, use among MSM in Washington, DC and MiamiDade County, FL remains low. Geographic difference in willingness to use PrEP between 2011 and 2014 highlight the need for regionally tailored PrEP information and behavioral interventions to increase willingness and use among MSM. With the expansion of PrEP services in both jurisdictions, access to PrEP should be explored in future analyses.
